Submit Deal

Announced

28 Mar 2018

ICON BIOSCIENCE INC / EYEPOINT PHARMACEUTICALS INC / Acquisition / Private / £70m

Synopsis

US$100 million acquisition of Icon Bioscience, Inc., a specialty biopharmaceutical company.

Principals

target

Icon Bioscience

bidder

Eyepoint Pharmaceuticals

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (12)

lindsey owings

Counsel at Hogan Lovells

Lawyer

bidder

Deals

£ 2.12 B

Total Value

steven j. abrams

Partner at Hogan Lovells

Lawyer

bidder

Deals

£ 503 M

Total Value

cullen taylor

Partner at Hogan Lovells

Lawyer

bidder

Deals

£ 1.70 B

Total Value

michael applebaum

Counsel at Hogan Lovells

Lawyer

bidder

Deals

£ 36.22 B

Total Value

teresa lavenue

Counsel at Hogan Lovells

Lawyer

bidder

Deals

£ 142 M

Total Value

lauren battaglia

Senior Associate at Hogan Lovells

Lawyer

bidder

Deals

£ 77.32 B

Total Value

seaton thedinger

Counsel at Hogan Lovells

Lawyer

bidder

Deals

£ 20.48 B

Total Value

katie kelly

Associate at Hogan Lovells

Lawyer

bidder

Deals

£ 5.25 B

Total Value

katie cooperman

Senior Associate at Hogan Lovells

Lawyer

bidder

Deals

£ 1.98 B

Total Value

joseph eng

Hogan Lovells

Lawyer

bidder

Deals

£ 71 M

Total Value

robin samuel

Hogan Lovells

Lawyer

bidder

Deals

£ 119 M

Total Value

stuart langbein

Hogan Lovells

Lawyer

bidder

Deal

£ 71 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy